SLC5A2 and diabetic cardiomyopathy: Further combined with the overlay visualization analysis of co-occurring keywords such as “heart failure,” “diabetic cardiomyopathy” “ejection fraction,” “fibrosis,” and “ampk,” the potential molecular mechanism of SGLT2 inhibitors in heart failure and diabetic cardiomyopathy has become a research hotspot in recent years.